Klotho Neurosciences (KLTO) Competitors $1.11 -0.08 (-6.66%) As of 12:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KLTO vs. FTLF, ALTS, FATE, NMRA, IMRX, NKTX, RAPT, GLSI, ACTU, and KRROShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include FitLife Brands (FTLF), ALT5 Sigma (ALTS), Fate Therapeutics (FATE), Neumora Therapeutics (NMRA), Immuneering (IMRX), Nkarta (NKTX), Rapt Therapeutics (RAPT), Greenwich LifeSciences (GLSI), Actuate Therapeutics (ACTU), and Korro Bio (KRRO). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Its Competitors FitLife Brands ALT5 Sigma Fate Therapeutics Neumora Therapeutics Immuneering Nkarta Rapt Therapeutics Greenwich LifeSciences Actuate Therapeutics Korro Bio FitLife Brands (NASDAQ:FTLF) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation. Which has more risk & volatility, FTLF or KLTO? FitLife Brands has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Klotho Neurosciences has a beta of 11.08, indicating that its stock price is 1,008% more volatile than the S&P 500. Do analysts recommend FTLF or KLTO? FitLife Brands currently has a consensus price target of $20.50, indicating a potential upside of 46.06%. Given FitLife Brands' stronger consensus rating and higher probable upside, analysts plainly believe FitLife Brands is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings & valuation, FTLF or KLTO? FitLife Brands has higher revenue and earnings than Klotho Neurosciences. Klotho Neurosciences is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFitLife Brands$64.47M2.04$8.98M$0.8416.71Klotho NeurosciencesN/AN/A-$6.15M-$0.36-3.09 Do insiders and institutionals believe in FTLF or KLTO? 2.3% of FitLife Brands shares are owned by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are owned by institutional investors. 61.3% of FitLife Brands shares are owned by insiders. Comparatively, 26.7% of Klotho Neurosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is FTLF or KLTO more profitable? FitLife Brands has a net margin of 13.85% compared to Klotho Neurosciences' net margin of 0.00%. FitLife Brands' return on equity of 25.59% beat Klotho Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets FitLife Brands13.85% 25.59% 15.26% Klotho Neurosciences N/A -1,779.01%-275.01% Does the media favor FTLF or KLTO? In the previous week, Klotho Neurosciences had 1 more articles in the media than FitLife Brands. MarketBeat recorded 3 mentions for Klotho Neurosciences and 2 mentions for FitLife Brands. Klotho Neurosciences' average media sentiment score of 0.91 beat FitLife Brands' score of 0.00 indicating that Klotho Neurosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Klotho Neurosciences 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryFitLife Brands beats Klotho Neurosciences on 12 of the 16 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.09M$2.41B$5.50B$9.01BDividend YieldN/A1.77%5.39%4.11%P/E Ratio-3.098.9727.4220.07Price / SalesN/A467.40398.50109.13Price / CashN/A151.5836.1356.90Price / Book27.774.618.015.70Net Income-$6.15M$31.34M$3.16B$248.47M7 Day Performance-1.70%0.86%2.08%2.92%1 Month Performance537.29%7.90%4.38%5.77%1 Year PerformanceN/A1.89%35.81%21.39% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$1.11-6.7%N/AN/A$36.09MN/A-3.09N/ANews CoverageFTLFFitLife Brands4.3892 of 5 stars$14.14+8.6%$20.50+45.0%-19.0%$132.78M$64.47M16.8320ALTSALT5 Sigma0.2102 of 5 stars$7.57+4.6%N/AN/A$132.10M$12.53M0.00170High Trading VolumeFATEFate Therapeutics4.1026 of 5 stars$1.14+1.8%$3.83+236.3%-65.2%$130.64M$13.63M-0.77550NMRANeumora Therapeutics2.5974 of 5 stars$0.80+8.6%$9.29+1,066.1%-92.0%$128.80MN/A-0.49108News CoveragePositive NewsGap UpIMRXImmuneering4.0767 of 5 stars$3.44+2.1%$13.25+285.2%+229.4%$123.81M$320K-1.7660Positive NewsGap UpNKTXNkarta2.2773 of 5 stars$1.71+3.0%$14.33+738.2%-66.9%$121.34MN/A-1.13140News CoverageRAPTRapt Therapeutics4.187 of 5 stars$7.33-8.4%$24.00+227.4%-64.1%$121.24M$1.53M-0.3880GLSIGreenwich LifeSciences1.9317 of 5 stars$9.05-0.2%$39.00+330.9%-43.8%$121.00MN/A-7.183ACTUActuate Therapeutics2.9372 of 5 stars$6.13+0.3%$20.50+234.4%N/A$120.27MN/A0.0010Positive NewsInsider TradeHigh Trading VolumeKRROKorro Bio2.55 of 5 stars$12.77+2.2%$102.43+702.1%-60.5%$119.91M$2.27M-1.3570 Related Companies and Tools Related Companies FitLife Brands Competitors ALT5 Sigma Competitors Fate Therapeutics Competitors Neumora Therapeutics Competitors Immuneering Competitors Nkarta Competitors Rapt Therapeutics Competitors Greenwich LifeSciences Competitors Actuate Therapeutics Competitors Korro Bio Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLTO Stock Alerts